Recruitment was based on clinical diagnosis, rather than neuropathology or genetics, but the clinical diagnosis was reconfirmed at serial clinical visits and has high clinicopathological correlation with either frontotemporal lobar degeneration (FTLD)–tau or FTLD–TDP‐43. The gene discussed is MAPT; the disease is frontotemporal dementia.